Use of Rodent Models in the Discovery of Novel Anthelmintics

Parasitic Helminths: Targets, Screens, Drugs and Vaccines

Volumn , Issue , 2012, Pages 181-199

  Fankhauser, Rebecca ^a   Cozzie, Linsey R ^a   Nare, Bakela ^b   Powell, Kerrie ^b   Sluder, Ann E ^b   Hammerland, Lance G ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b Scynexis Inc   (United States)

Author keywords

Anthelmintic drug; Filarid; Flatworm; Nematode; Parasite; Rodent model

Indexed keywords

EID: 84886219075     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527652969.ch11     Document Type: Chapter

References (123)

1. Woods, D.J. and Williams, T.M. (2007) The challenges of developing novel antiparasitic drugs. Invert. Neurosci., 7, 245-250.
2. Booth, B. and Zemmel, R. (2004) Prospects for productivity. Nat. Rev. Drug Discov., 2, 451-456.
3. Hutchinson, L. and Kirk, R. (2011) High drug attrition rates - where are we going wrong? Nat. Rev. Clin. Oncol., 8, 189-190.
4. Holmes, P. (2003) Rodent models of depression: reexamining validity without anthropomorphic inference. Crit. Rev. Neurobiol., 15, 143-174.
5. Nemeth, E.F., Heaton, W.H., Miller, M., Fox, J., Balandrin, M.F., Van Wagenen, B.C., Colloton, M. et al. (2004) Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J. Pharmacol. Exp. Ther., 308, 627-635.
6. Shahapuni, I., Monge, M., Oprisiu, R., Mazouz, H.,Westeel, P.F., Moriniére, P., Massy, Z. et al. (2006) Drug insight: renal indications of calcimimetics. Nat. Clin. Pract. Nephrol., 6, 316-325.
7. Rothwell, J.T., Sangster, N.C., Conder, G.A., Dobson, R.J., and Johnson, S.S. (1993) Kinetics of expulsion of Haemonchus contortus from sheep and jirds after treatment with closantel. Int. J. Parasitol., 23, 885-889.
8. Sutherland, I.A., Bailey, J., and Shaw, R.J. (2010) The production costs of anthelmintic resistance in sheep managed within a monthly preventive drench program. Vet. Parasitol., 171, 300-304.
9. Sutherland, I.A. and Leathwick, D.M. (2011) Anthelmintic resistance in nematode parasites of cattle: a global issue? Trends Parasitol., 27, 176-181.
10. Corwin, R.M. (1997) Economics of gastrointestinal parasitism of cattle. Vet. Parasitol., 72, 451-457.
11. Mohamed, A.S., Moore, G.E., and Glickman, L.T. (2009) Prevalence of intestinal nematode parasitism among pet dogs in the United States (2003-2006). J. Am. Vet.Med. Assoc., 234, 631-637.
12. McCall, J.W., Gench, C., Kramer, L.H., Guerrero, J., and Venco, L. (2008) Heartworm disease in animals and humans. Adv. Parasitol., 66, 193-285.
13. Scott, I. and Sutherland, I. (2010) Gastrointestinal Nematodes of Sheep and Cattle: Biology and Control, Wiley-Blackwell, Ames, IA.
14. Radostits, O.M., Gay, C.C., Blood, D.C. and Hinchcliff, K.W. (eds) (1999) Diseases caused by helminth parasites: nematode diseases of the alimentary tract, in VeterinaryMedicine: ATextbook of the Diseases of Cattle, Sheep, Pigs, Goats and Horses, 9th edn, Saunders, St Louis, MO, pp. 1339-1350.
15. Zavadovskii, M.M. and Zakharova, M. (1931) Artificial infection of guinea-pigs with Trichostrongylus extenuatus and Trichostrongylus instabilis. Trudy Dinamike Razvit., 6, 303-305.
16. Herlich, H., Douvres, F.W., and Isenstein, R.S. (1956) Experimental infections of guinea pigs with Trichostrongylus colubriformis, a parasite of ruminants. Proc. Helm. Soc.Wash., 23, 104-105.
17. Herlich, H. (1958) Further observations on the experimental host-parasite relations of the guinea pig and the ruminant parasite, Trichostrongylus colubriformis. J. Parasitol., 44, 602.
18. Sturrock, R.F. (1963) Observations on the use of Trichostrongylus colubriformis (Nematoda) infections of guinea-pigs for laboratory experiments. Parasitology, 53, 189-199.
19. Williams, G.A.H. and Palmer, B.H. (1964) Trichostrongylus colubriformis (a nematode parasite of sheep and other ruminants) as a test organism in screening for sheep anthelmintics in the laboratory. Nature, 203, 1399-1400.
20. Kelly, J.D., Sangster, N.C., Porter, C.J., Martin, I.C.A., and Gunawan, M. (1981) Use of guinea pigs to assay anthelmintic resistance in ovine isolates of Trichostrongylus colubriformis. Res. Vet. Sci., 30, 131-137.
21. Kates, K.C. and Thompson, D.E. (1968) Susceptibility of gerbils and young white rats to simultaneous infection with Trichostrongylus axei and Trichostrongylus colubriformis. Proc. Helm. Soc. Wash., 35, 102-106.
22. Gration, K.A.F., Bishop, B.F., Martin-Short, M.R., and Herbert, A. (1992) A new anthelmintic assay using rats infected with Trichostrongylus colubriformis. Vet. Parasitol., 42, 273-279.
23. LeLand, S.E. Jr (1961) Studies on Trichostrongylus axei (Cobbold, 1879). VII. Some quantitative aspects of experimental infection of the Mongolian gerbil (Meriones unguiculatus). J. Parasitol., 49, 617-622.
24. Kates, K.C. and Thompson, D.E. (1967) Activity of three anthelmintics against mixed infections of two Trichostrongylus species in gerbils, sheep and goats. Proc. Helm. Soc. Wash., 34, 228-236.
25. Wagland, B.M., Abeydeera, L.R., Rothwell, T.L.W., and Ouwerkerk, D. (1989) Experimental Haemonchus contortus infections in guinea pigs. Int. J. Parasitol., 19, 301-305.
26. Adams, D.B. (1990) Infection of immunosuppressed mice with the abomasal nematode parasite of ruminants, Haemonchus contortus. Int. J. Parasitol., 20, 631-636.
27. Conder, G.A., Jen, L.W., Marbury, K.S., Johnson, S.S., Guimond, P.M., Thomas, E.M., and Lee, B.L. (1990) A novel anthelmintic model utilizing jirds,Meriones unguiculatus, infected with Haemonchus contortus. J. Parasitol., 76, 168-170.
28. De Jesús-Gabino, A.F., Mendoza-de Gives, P., Salinas-Sánchez, D.O., López-Arellano, M.E., Liébano-Hernández, E., Hernández-Velázquez, V.M., and Valladares-Cisneros, G. (2010) Anthelmintic effects of Prosopis laevigata n-hexanic extract against Haemonchus contortus in artificially infected gerbils (Meriones unguiculatus). J. Helminthol., 84, 71-75.
29. Squires, J.M., Foster, J.G., Lindsay, D.S., Caudell, D.L., and Zajac, A.M. (2010) Efficacy of an orange oil emulsion as an anthelmintic against Haemonchus contortus in gerbils (Meriones unguiculatus) and in sheep. Vet. Parasitol., 172, 95-99.
30. Squires, J.M., Ferreira, J.F., Lindsay, D.S., and Zajac, A.M. (2011) Effects of artemisinin and Artemisia extracts on Haemonchus contortus in gerbils (Meriones unguiculatus). Vet. Parasitol., 175, 103-108.
31. Conder, G.A., Johnson, S.S., Guimond, P.M., Cox, D.L., and Lee, B.L. (1991) Concurrent infections with the ruminant nematodes Haemonchus contortus and Trichostrongylus colubriformis in jirds, Meriones unguiculatus, and use of this model for anthelmintic studies. J. Parasitol., 77, 621-623.
32. Kaminsky, R., Ducray, P., Jung, M., Clover, R., Rufener, L., Bouvier, J., Weber, S.S. et al. (2008) A new class of anthelmintics effective against drugresistant nematodes. Nature, 452, 176-180.
33. Kaminsky, R., Gauvry, N., Schorderet Weber, S., Skripsky, T., Bouvier, J., Wenger, A., Shroeder, F. et al. (2008) Identification of the amino-acetonitrile derivative monepantel (AAD 1566) as a new anthelmintic drug development candidate. Parasitol. Res., 103, 931-939.
34. Court, J.P., Lees, G.M., Coop, R.L., Angus, K.W., and Beesley, J.E. (1988) An attempt to produce Ostertagia circumcincta infections in Mongolian gerbils. Vet. Parasitol., 28, 79-91.
35. Conder, G.A., Johnson, S.S., Nowakowski, D.S., Blake, T.E., Dutton, F.E., Nelson, S.J., Thomas, E.M. et al. (1995) Anthelmintic profile of the cyclodepsipeptide PF1022A in in vitro and in vivo models. J. Antibiot., 48, 820-823.
36. Ostlind, D.A., Cifelli, S., Mickle, W.G., Smith, S.K., Ewanciw, D.V., Rafalko, B., Felcetto, T., and Misura, A. (2006) Evaluation of broad-spectrum anthelmintics activity in a novel assay against Haemonchus contortus, Trichostrongylus colubriformis, and T. sigmodontis in the gerbil Meriones unguiculatus. J. Helminthol., 80, 393-396.
37. Keiser, J. and Utzinger, J. (2008) Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. J. Am. Med. Assoc., 299, 1937-1948.
38. Mahmoud, A.A. (1996) Strongyloidiasis. Clin. Infect. Dis., 23, 949-952.
39. Hotez, P.J. and Kamath, A. (2009) Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl. Trop. Dis., 3, e412.
40. Harhay, M.O., Horton, J., and Olliaro, P.L. (2010) Epidemiology and control of human gastrointestinal parasites in children. Expert Rev. Anti Infect. Ther., 8, 219-234.
41. Hotez, P.J., Bundy, D.A.P., Beegle, K., Brooker, S., Drake, L., de Silva, N., Montresor, A. et al. (2006) Helminth infections: soil-transmitted helminth infections and schistosomiasis, in Disease Control Priorities in Developing Countries, 2nd edn (eds D.T. Jamison, J.G. Breman, A.R. Measham, G. Alleyne, M. Claeson, D.B. Evans, P. Jha, A. Mills, and P. Musgrove), World Bank Publications, Washington, DC, pp. 467-482.
42. Olliaro, P., Seiler, J., Kuesel, A., Horton, J., Clark, J.N., Don, R., and Keiser, J. (2011) Potential drug development candidates for human soil-transmitted helminthiases. PLoS Negl. Trop. Dis., 5, e1138.
43. Cross, J.H. (1996) Enteric nematodes of humans, in Medical Microbiology, 4th edn (ed. S. Baron), University of Texas Medical Branch, Galveston, TX, pp. 1065-1177.
44. Boes, J. andHelwigh, A.B. (2000) Animal models of intestinal nematode infections of humans. Parasitology, 121 (Suppl.), S97-S111.
45. Cliffe, L.J. and Grencis, R.K. (2004) The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection. Adv. Parasitol., 57, 255-307.
46. Bungiro, R. and Cappello, M. (2011) Twenty-first century progress toward the global control of human hookworm infection. Curr. Infect. Dis. Rep., 13, 210-217.
47. Sen, H.G. and Seth, D. (1970) Development of Necator americanus in golden hamsters Mesocricetus auratus. Indian J. Med. Res., 58, 1356-1360.
48. Sen, H.G. (1972) Necator americanus: behaviour in hamsters. Exp. Parasitol., 32, 26-32.
49. Sen, H.G. and Deb, B.N. (1973) Effect of cortisone upon serial passage with the human hookworm, Necator americanus in golden hamsters, Mesocricetus auratus. Indian J. Med. Res., 61, 486-494.
50. Bungiro, R.D., Anderson, B.R., and Cappello, M. (2003) Oral transfer of adult Ancylostoma ceylanicum hookworms into permissive and nonpermissive host species. Infect. Immun., 71, 1880-1886.
51. Murthy, P.K., Joseph, S.K., and Murthy, P.S. (2011) Plant products in the treatment and control of filariasis and other helminth infections and assay systems for antifilarial/anthelmintic activity. Planta Med., 77, 647-661.
52. Behnke, J.M., Paul, V., and Rajasekariah, G.R. (1986) The growth and migration of Necator americanus following infection of neonatal hamsters. Trans. R. Soc. Trop. Med. Hyg., 80, 146-149.
53. Xue, J., Xiao, S.H., Xu, L.L., and Qiang, H.Q. (2010) The effect of tribendimidine and its metabolites against Necator americanus in golden hamsters and Nippostrongylus braziliensis in rats. Parasitol. Res., 106, 775-781.
54. Siddiqui, A.A. and Berk, S.L. (2001) Diagnosis of Strongyloides stercoralis infection. Clin. Infect. Dis., 33, 1040-1047.
55. Nolan, T.J., Megyeri, Z., Bhopale, V.M., and Schad, G.A. (1993) Strongyloides stercoralis: the first rodent model for uncomplicated and hyperinfective strongyloidiasis, the Mongolian gerbil (Meriones unguiculatus). J. Infect. Dis., 168, 1479-1484.
56. Nolan, T.J., Bhopale, V.M., Rotman, H.L., Abraham, D., and Schad, G.A. (2002) Strongyloides stercoralis: high worm population density leads to autoinfection in the jird (Meriones unguiculatus). Exp. Parasitol., 100, 173-178.
57. Lok, J.B. (2007) Strongyloides stercoralis: a model for translational research on parasitic nematode biology, inWormBook (ed. The C. elegans Research Community), doi: 10.1895/ wormbook.1.134.1.
58. Steinmann, P., Zhou, X.N., Du, Z.W., Jiang, J.Y., Xiao, S.H., Wu, Z.X., Zhou, H., and Utzinger, J. (2008) Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp: open-label randomized trial. PLoS Negl. Trop. Dis., 2, e322.
59. Pawlowski, Z.S. (1982) Ascariasis: host-pathogen biology. Rev. Infect. Dis., 4, 806-814.
60. Katiyar, J.C., Gupta, S., and Sharma, S. (1989) Experimental models in drug development for helminthic diseases. Rev. Infect. Dis., 11, 638-654.
61. Addiss, D. (2010) The Global Alliance to Eliminate Lymphatic Filariasis. The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: a half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases. Parasit. Vectors, 3, 100.
62. Gupta, R., Tyagi, K., Jain, S.K., and Misra-Bhattacharya, S. (2003) Brugia malayi: establishment in inbred and outbred strains of mice. Exp. Parasitol., 103, 57-60.
63. Bockarie, M.J. and Deb, R.M. (2010) Elimination of lymphatic filariasis: do we have the drugs to complete the job? Curr. Opin. Infect. Dis., 23, 617-620.
64. Hewitt, R.I. and Wallace, W.S. (1947) Experimental chemotherapy of filariasis; experimental methods for testing drugs against naturally acquired filarial infections in cotton rats and dogs. J. Lab. Clin. Med., 32, 1293-1303.
65. Taubert, A. and Zahner, H. (2001) Cellular immune responses of filaria (Litomosoides sigmodontis) infected BALB/c mice detected on the level of cytokine transcription. Parasite Immunol., 23, 453-462.
66. Babayan, S., Ungeheuer, M.N., Martin, C., Attout, T., Belnoue, E., Snounou, G., Rénia, L. et al. (2003) Resistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactions. Infect. Immun., 71, 6820-6829.
67. Taylor, M.D., LeGoff, L., Harris, A., Malone, E., Allen, J.E., andMaizels, R.M. (2005) Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J. Immunol., 174, 4924-4933.
68. Lawrence, R.A. (1996) Lymphatic filariasis: what mice can tell us. Parasitol. Today, 12, 267-271.
69. Singh, P.K., Ajay, A., Kushwaha, S., Tripathi, R.P., and Misra-Bhattacharya, S. (2010) Towards novel antifilarial drugs: challenges and recent developments. Future Med. Chem., 2, 251-283.
70. Ash, L.R. and Riley, J.M. (1970) Development of Brugia pahangi in the jird, Meriones unguiculatus, with notes on infections in other rodents. J. Parasitol., 56, 962-968.
71. McCall, J.W., Malone, J.B., Hyong-Sun, A., and Thompson, P.E. (1973) Mongolian jirds (Meriones unguiculatus) infected with Brugia pahangi by the intraperitoneal route: a rich source of developing larvae, adult filariae, and microfilariae. J. Parasitol., 59, 436.
72. Allen, J.E., Adjei, O., Bain, O., Hoerauf, A., Hoffmann, W.H., Makepeace, B.L., Schulz-Key, H. et al. (2008) Of mice, cattle, and humans: the immunology and treatment of river blindness. PLoS Negl. Trop. Dis., 2, e217.
73. Gloeckner, C., Garner, A.L., Mersha, F., Oksov, Y., Tricoche, N., Eubanks, L.M., Lustigman, S. et al. (2010) Repositioning of an existing drug for the neglected tropical disease Onchocerciasis. Proc. Natl. Acad. Sci. USA, 107, 3424-3429.
74. Müllner, A., Helfer, A., Kotlyar, D., Oswald, J., and Efferth, T. (2011) Chemistry and pharmacology of neglected helminthic diseases. Curr.Med. Chem., 18, 767-789.
75. Schweizer, G., Braun, U., Deplazes, P., and Torgerson, P.R. (2005) Estimating the financial losses due to bovine fasciolosis in Switzerland. Vet. Rec., 157, 188-193.
76. Sargison, N.D. and Scott, P.R. (2011) Diagnosis and economic consequences of triclabendazole resistance in Fasciola hepatica in a sheep flock in south-east Scotland. Vet. Rec., 168, 159.
77. Cioli, D. and Pica-Mattoccia, L. (2003) Praziquantel. Parasitol. Res., 90, S3-S9.
78. Utzinger., J., Raso, G., Brooker, S., De Savigny, D., Tanner, M., Ornbjerg, N., Singer, B.H., and N'goran, E.K. (2009) Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology, 136, 1859-1874.
79. Lamberton, P.H., Hogan, S.C., Kabatereine, N.B., Fenwick, A., and Webster, J.P. (2010) In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections. Am. J. Trop. Med. Hyg., 83, 1340-1347.
80. Sabah, A.A., Fletcher, C.,Webbe, G., and Doenhoff, M.J. (1986) Schistosoma mansoni: chemotherapy of infections of different ages. Exp. Parasitol., 61, 294-303.
81. Xiao, S.H., Yue, W.J., Yang, Y.Q., and You, J.Q. (1987) Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. Chin. Med. J., 100, 759-768.
82. Xiao, S.H.,Mei, J.Y., and Jiao, P.Y. (2009) The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum. Parasitol. Res., 106, 237-246.
83. Dong, Y., Chollet, J., Vargas, M., Mansour, N.R., Bickle, Q., Alnouti, Y., Huang, J., Keiser, J., and Vennerstrom, J.L. (2010) Praziquantel analogs with activity against juvenile Schistosoma mansoni. Bioorg. Med. Chem. Lett., 20, 2481-2484.
84. Coles, G.C. (1999) Schistosomosis, in Handbook of Animal Models of Infection (eds O. Zak and M.A. Sande), Academic Press, London, pp. 873-884.
85. el Kouni, M.H. (1991) Efficacy of combination therapy with tubercidin and nitrobenzylthioinosine 50-monophosphate against chronic and advanced stages of schistosomiasis. Biochem. Pharmacol., 41, 815-820.
86. Penido, M.L., Nelson, D.L., Vieira, L.Q.,Watson, D.G., andKusel, J.R. (1995) Metabolism by Schistosoma mansoni of a new schistosomicide: 2-[(1-methylpropyl)amino]-1-octanethiosulphuric acid. Parasitology, 111, 177-185.
87. Manivannan, B., Rawson, P., Jordan, T.W., Secor, W.E., and La Flamme1, A.C. (2010) Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis. Infect. Immun., 78, 618-628.
88. Pearce, E.J. and MacDonald, A.S. (2002) The immunobiology of schistosomiasis. Nat. Rev. Immunol., 2, 499-511.
89. Cheever, A.W., Lenzi, J.A., Lenzi, H.L., and Andrade, Z.A. (2002) Experimental models of Schistosoma mansoni infection. Mem. Inst. Oswaldo Cruz, 97, 917-940.
90. Lewis, F.A., Liang, Y.S., Raghavan, N., and Knight, M. (2008) The NIH-NIAID schistosomiasis resource center. PLoS Negl. Trop. Dis., 2, e267.
91. Sayed, A.A., Simeonov, A., Thomas, C.J., Inglese, J., Austin, C.P. et al. (2008) Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med., 14, 407-412.
92. Abdulla, M.H., Lim, K.C., Sajid, M., McKerrow, J.H., and Caffrey, C.R. (2007) Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med., 4, e14.
93. Keiser, J. (2010) In vitro and in vivo trematode models for chemotherapeutic studies. Parasitology, 137, 589-603.
94. Keiser, J., Shu-Hua, X., Tanner, M., and Utzinger, J. (2006) Artesunate and artemether are effective fasciolicides in the rat model and in vitro. J. Antimicrob. Chemother., 57, 1139-1145.
95. McConville, M., Brennan, G.P., Flanagan, A., Edgar, H.W., Hanna, R.E., McCoy, M., Gordon, A.W. et al. (2009) An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica. Vet. Parasitol., 162, 75-88.
96. McKinstry, B., Fairweather, I., Brennan, G.P., and Forbes, A.B. (2003) Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax). Parasitol. Res., 91, 251-263.
97. Keiser, J. and Morson, G. (2008) Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether. Exp. Parasitol., 118, 228-237.
98. Saric, J., Li, J.V., Wang, Y., Keiser, J., Veselkov, K., Dirnhofer, S., Yap, I.K., Nicholson, J.K., Holmes, E., and Utzinger, J. (2009) Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouse. J. Proteome Res., 8, 3899-3911.
99. Keiser, J., Utzinger, J., Tanner, M., Dong, Y., and Vennerstrom, J.L. (2006) The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica. J. Antimicrob. Chemother., 58, 1193-1197.
100. Keiser, J., Brun, R., Fried, B., and Utzinger, J. (2006) Trematocidal activity of praziquantel and artemisinin derivatives: in vitro and in vivo investigations with adult Echinostoma caproni. Antimicrob. Agents Chemother., 50, 803-805.
101. Sariözkan, S. and Yalçin, C. (2009) Estimating the production losses due to cystic echinococcosis in ruminants in Turkey. Vet. Parasitol., 163, 330-334.
102. Kamiya, M. and Sato, H. (1990) Complete life cycle of the canid tapeworm, Echinococcus multilocularis, in laboratory rodents. FASEB J., 4, 3334-3339.
103. Romig, T. and Bilger, B. (1999) Animal models for echinococcosis, in Handbook of Animal Models of Infection (eds O. Zak and M.A. Sande), Academic Press, London, pp. 877-884.
104. Taylor, D.H., Morris, D.L., Reffin, D., and Richards, K.S. (1989) Comparison of albendazole mebendazole and praziquantel chemotherapy of Echinoccocus multilocularis in a gerbil model. Gut., 30, 1401-1405.
105. Johnson, S.S., Thomas, E.M., and Geary, T.G. (1999) Cestode model: Hymenolepis diminuta in the jird, in Handbook of Animal Models of Infection (eds O. Zak and M.A. Sande), Academic Press, London, pp. 892-896.
106. Drudge, J.H., Leland, S.E. Jr, Wyant, Z.N., and Elam, G.W. (1955) Studies on Trichostrongylus axei (Cobbold, 1879) I. Some experimental host relationships. J. Parasitol., 41, 505-511.
107. Panitz, E. and Shum, K.L. (1981) Efficacy of four anthelmintics in Trichostrongylus axei or T. colubriformis infections in the gerbil, Meriones unguiculatus. J. Parasitol., 67, 135-136.
108. Boersema, J.H. (1985) Chemotherapy of gastrointestinal nematodiasis in ruminants, in Chemotherapy of GastrointestinalHelminths (eds H.Vanden Bossche, D. Thienpont, and P.G. Janssens), Springer, New York, pp. 407-442.
109. Zahner, H. and Schares, G. (1993) Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds inMastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi. Acta Trop., 52, 221-266.
110. Townson, S., Connelly, C., Dobinson, A., andMuller,R. (1987) Drug activity against Onchocerca gutturosa males in vitro: a model for chemotherapeutic research on onchocerciasis. J. Helminthol., 61, 271-281.
111. Tagboto, S.K. and Townson, S. (1996) Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo. Ann. Trop. Med. Parasitol., 90, 497-505.
112. Mehlhorn, H., Schmahl, G., and Mevissen, I. (2005) Efficacy of a combination of imidacloprid and moxidectin against parasites of reptiles and rodents: case reports. Parasitol. Res., 97, S97-S101.
113. Mehlhorn, H., Schmahl, G., Frese, M., Mevissen, I., Harder, A., and Krieger, K. (2005) Effects of a combinations of emodepside and praziquantel on parasites of reptiles and rodents. Parasitol. Res., 97, S65-S69.
114. Rajasekariah, G.R., Dhage, K.R., Deb, B.N., and Bose, S. (1985) Necator americanus and Ancylostoma ceylanicum: development of protocols for dual infection in hamsters. Acta Trop., 42, 45-54.
115. Xue, J., Qiang, H.Q., Yao, J.M., Fujiwara, R., Zhan, B., Hotez, P., and Xiao, S.H. (2005) Necator americanus: optimization of the golden hamster model for testing anthelmintic drugs. Exp. Parasitol., 111, 219-223.
116. Behnke, J.M., Tose, R., and Garside, P. (1993) Sensitivity to ivermectin and pyrantel of Ancylostoma ceylanicum and Necator americanus. Int. J. Parasitol., 23, 945-952.
117. Grove, D. (1982) Strongyloides ratti and S. stercoralis: the effects of thiabendazole, mebendazole, and cambendazole in infected mice. Am. J. Trop.Med. Hyg., 31, 469-476.
118. Cioli, D., Pica-Mattoccia, L., and Archerm, S. (1995) Antischistosomal drugs: past, present and future. Clin. Pharmacol. Ther., 68, 35-85.
119. Keiser, J., El Ela, N.A., El Komy, E., El Lakkany, N., Diab, T., Chollet, J., Utzinger, J., and Barakat, R. (2006) Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model. Am. J. Trop. Med. Hyg., 75, 287-291.
120. Xiao, S.H. and Catto, B.A. (1989) In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother., 33, 1557-1562.
121. Keiser, J., Chollet, J., Xiao, S.H.,Mei, J.Y., Jiao, P.Y., Utzinger, J., and Tanner, M. (2009) 2009 Mefloquine - an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis., 3, e350.
122. Xiao, S.H., Keiser, J., Chollet, J., Utzinger, J., Dong, Y., Endriss, Y., Vennerstrom, J.L., and Tanner, M. (2007) In vitro and in vivo activities of synthetic trioxolanes against major human Schistosome species. Antimicrob. Agents Chemother., 51, 1440-1445.
123. Keiser, J. and Utzinger, J. (2007) Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr. Opin. Infect. Dis., 20, 605-612.